Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Piramal Boosts N American Capacity With Ash Stevens Deal

Executive Summary

Cash-flush Piramal Enterprises is ramping up its North American drug manufacturing operations through the purchase of Ash Stevens, a US company making high-potency active pharmaceutical ingredients, in the latest in a string of deals for the unconventional Indian group.

You may also be interested in...

Piramal Eyes 20% Pharma Stake Sale

Piramal Enterprises, one of India’s biggest conglomerates, has said it is looking to sell up to a 20% stake in its Piramal Healthcare business to raise funds for spurring growth of the division through acquisitions.

How Piramal Plans To Scale Up In Critical Care, Build On Acquisitions

Peter DeYoung, CEO of Piramal Critical Care, expects to build “profitable growth positions” from the injectable products acquired from Janssen. He is also upbeat about the commercialization prospects in Europe for intrathecal baclofen and the potential launch of the first desflurane generic in the US.

India's Piramal Adds Four Pfizer Consumer Brands Pursuing Market Lead

The consumer goods arm of Piramal Enterprises makes its third acquisition in six months, keeping up a hectic deal-making pace in its quest to be one of India’s leading OTC players.


Related Companies

Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts